Cargando…
Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer
Amplification of pro-oncogenic kinases is a common genetic alteration driving tumorigenic phenotypes. Cancer cells rely on the amplified kinases to sustain cell proliferation, survival, and growth, presenting an opportunity to develop therapies targeting the amplified kinases. Utilizing small molecu...
Autores principales: | Torres-Ayuso, Pedro, Brognard, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092480/ https://www.ncbi.nlm.nih.gov/pubmed/35115411 http://dx.doi.org/10.1124/molpharm.121.000306 |
Ejemplares similares
-
G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation
por: Melick, Chase H., et al.
Publicado: (2022) -
Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
por: Lamore, Sarah D., et al.
Publicado: (2017) -
Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets
por: Torres-Ayuso, Pedro, et al.
Publicado: (2019) -
Diagnosis and Treatment of Pancreas Rejection
por: Redfield, R. R., et al.
Publicado: (2015) -
New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
por: Bensen, Ryan, et al.
Publicado: (2021)